Stock Research: Steris

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Steris

NYSE:STE IE00BFY8C754
64
  • Value
    22
  • Growth
    45
  • Safety
    Safety
    73
  • Combined
    45
  • Sentiment
    72
  • 360° View
    360° View
    64
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

STERIS Plc provides products and services focused on infection prevention. It operates in Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The company serves healthcare providers worldwide, medical device and pharmaceutical manufacturers globally, and biopharmaceutical and medical device research and manufacturing facilities. In the last fiscal year, the company had a market cap of $22,511 million, profits of $2,403 million, revenue of $5,460 million, and 17,787 employees.

more
Index
Employee Focus EU
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 22 29 43
Growth
45 76 87 67
Safety
Safety
73 26 15 41
Sentiment
72 40 63 87
360° View
360° View
64 28 53 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
62 65 78 90
Opinions Change
63 23 29 50
Pro Holdings
n/a 65 64 86
Market Pulse
13 21 42 24
Sentiment
72 40 63 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 22 29 43
Growth
45 76 87 67
Safety Safety
73 26 15 41
Combined
45 23 25 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
28 41 42 36
Price vs. Earnings (P/E)
17 23 28 33
Price vs. Book (P/B)
38 34 34 56
Dividend Yield
39 39 40 42
Value
22 22 29 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
44 45 55 56
Profit Growth
57 36 57 58
Capital Growth
6 89 62 51
Stock Returns
71 60 83 63
Growth
45 76 87 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
70 36 38 52
Refinancing
27 17 33 35
Liquidity
75 42 30 47
Safety Safety
73 26 15 41

Similar Stocks

Discover high‑ranked alternatives to Steris and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Quilter

LSE:QLT
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carl Zeiss Meditec

XTRA:AFX
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: